Long term treatment outcome in multi drug resistant tuberculosts(MDR-TB)

被引：2
|
作者：
Prasad, R [1 ]
机构：
[1] Med Univ, Lucknow, Uttar Pradesh, India
来源：
CHEST | 2004年 / 126卷 / 04期
关键词：
D O I：
10.1378/chest.126.4_MeetingAbstracts.836S
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：836S / 836S
页数：1
相关论文
共 50 条
  • [21] Incidence of multi drug resistant tuberculosis (MDR-TB) in extrapulmonary tuberculosis cases in Northern India
    Maurya, A. K.
    Kant, S.
    Nag, V. L.
    Kushwaha, R. A. S.
    Kumar, M.
    Jain, S.
    Dhole, T. N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S27 - S27
  • [22] Long term treatment outcome in multi drug resistant tuberculosis
    Prasad, Rajendra
    Singh, Abhijeet
    Verma, Sanjay
    Kushwaha, Ramawadh Singh
    Garg, Rajiv
    Verma, Sanjeev Kumar
    Srivastava, Rahul
    Jain, Amita
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [23] Shorter drug regimens for MDR-TB
    不详
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2016, 94 (06) : 410 - 410
  • [24] Clinical management improves the treatment outcome of MDR-TB patients
    Chen, Ling
    Liu, Quanxian
    Li, Yuqin
    Zhang, Jianyong
    Zhang, Hong
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [25] Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
    Koirala, S.
    Borisov, S.
    Danila, E.
    Mariandyshev, A.
    Shrestha, B.
    Lukhele, N.
    Dalcolmo, M.
    Shakya, S. R.
    Miliauskas, S.
    Kuksa, L.
    Manga, S.
    Aleksa, A.
    Denholm, J. T.
    Khadka, H. B.
    Skrahina, A.
    Diktanas, S.
    Ferrarese, M.
    Bruchfeld, J.
    Koleva, A.
    Piubello, A.
    Koirala, G. S.
    Udwadia, Z. F.
    Palmero, D. J.
    Munoz-Torrico, M.
    Gc, R.
    Gualano, G.
    Grecu, V., I
    Motta, I
    Papavasileiou, A.
    Li, Y.
    Hoefsloot, W.
    Kunst, H.
    Mazza-Stalder, J.
    Payen, M-C
    Akkerman, O. W.
    Bernal, E.
    Manfrin, V
    Matteelli, A.
    Hamdan, H. Mustafa
    Marcos, M. Nieto
    Cadinanos Loidi, J.
    Cebrian Gallardo, J. J.
    Duarte, R.
    Escobar Salinas, N.
    Gomez Rosso, R.
    Laniado-Laborin, R.
    Martinez Robles, E.
    Quiros Fernandez, S.
    Rendon, A.
    Solovic, I
    PULMONOLOGY, 2021, 27 (05): : 403 - 412
  • [26] Management of multidrug resistant tuberculosis (MDR-TB) - Monitoring is the key to successful outcome
    Akshata, J. S.
    Chakrabarthy, Anushree
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2016, 65 (02): : 447 - 450
  • [27] Impact of diabetes mellitus on MDR-TB outcome
    Evelina, Lesnic
    Malic, Alina
    Niguleanu, Adriana
    Maximovici, Veronica
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [28] Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment
    Ormerod, LP
    BRITISH MEDICAL BULLETIN, 2005, 73-74 : 17 - 24
  • [29] New Drugs for the Treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Schaberg, T.
    Otto-Knapp, R.
    Bauer, T.
    PNEUMOLOGIE, 2015, 69 (05): : 282 - 286
  • [30] Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)
    Bonnet, Maryline
    Bastard, Mathieu
    Du Cros, Philipp
    Atadjan, Khamraev
    Kimenye, Kamene
    Khurkhumal, Shazina
    Hayrapetyan, Armen
    Telnov, Alex
    Hewison, Cathy
    Varaine, Francis
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345